share_log

Is Doctorglasses ChainLtd (SZSE:300622) Using Too Much Debt?

Is Doctorglasses ChainLtd (SZSE:300622) Using Too Much Debt?

Doctorglasses ChainLtd (SZSE:300622)是否使用過多的債務?
Simply Wall St ·  10/04 03:48

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know worries about.' When we think about how risky a company is, we always like to look at its use of debt, since debt overload can lead to ruin. Importantly, Doctorglasses Chain Co.,Ltd. (SZSE:300622) does carry debt. But the real question is whether this debt is making the company risky.

霍華德·馬克斯在談到股價波動時說得很好,他表示,與其擔心股價波動,'我擔心的是永久性損失的可能性...每一個我認識的實際投資者都會擔心這個問題。' 當我們考慮一家公司有多大風險時,我們總是喜歡看看它使用債務的情況,因爲債務過多可能導致毀滅。重要的是,博士眼鏡鏈股份有限公司(SZSE:300622)確實承擔了債務。但真正的問題是,這筆債務是否讓公司變得太冒險。

What Risk Does Debt Bring?

債務帶來了什麼風險?

Generally speaking, debt only becomes a real problem when a company can't easily pay it off, either by raising capital or with its own cash flow. In the worst case scenario, a company can go bankrupt if it cannot pay its creditors. However, a more frequent (but still costly) occurrence is where a company must issue shares at bargain-basement prices, permanently diluting shareholders, just to shore up its balance sheet. Of course, debt can be an important tool in businesses, particularly capital heavy businesses. The first step when considering a company's debt levels is to consider its cash and debt together.

一般來說,只有當一家公司無法輕鬆償還債務時,債務才會成爲真正的問題,不管是通過融資還是憑藉自身現金流。最壞的情況是,如果公司無法償還其債權人,公司可能會破產。然而,更頻繁的(但仍然很昂貴)情況是公司必須以折價的價格發行股票,永久稀釋股東,只是爲了強化其資產負債表。當然,債務可以成爲企業中重要的工具,特別是對於重資產的企業。在考慮一家公司的債務水平時,第一步是考慮其現金和債務。

What Is Doctorglasses ChainLtd's Net Debt?

博士眼鏡鏈有限公司的淨債務是多少?

The image below, which you can click on for greater detail, shows that at June 2024 Doctorglasses ChainLtd had debt of CN¥35.0m, up from none in one year. But it also has CN¥250.6m in cash to offset that, meaning it has CN¥215.6m net cash.

下方的圖片展示了更詳細的情況,根據2024年6月的數據,博士眼鏡鏈有限公司的債務爲3500萬人民幣,比一年前增加了。但公司也有25060萬人民幣的現金來抵消,意味着淨現金爲21560萬人民幣。

big
SZSE:300622 Debt to Equity History October 4th 2024
SZSE:300622債務資產比歷史記錄2024年10月4日

A Look At Doctorglasses ChainLtd's Liabilities

博士眼鏡連鎖有限公司的負債情況

We can see from the most recent balance sheet that Doctorglasses ChainLtd had liabilities of CN¥325.8m falling due within a year, and liabilities of CN¥96.7m due beyond that. Offsetting these obligations, it had cash of CN¥250.6m as well as receivables valued at CN¥133.7m due within 12 months. So it has liabilities totalling CN¥38.2m more than its cash and near-term receivables, combined.

從最近的資產負債表可以看出,博士眼鏡連鎖有限公司有着到期一年內的負債人民幣32580萬,到期超過一年的負債金額爲人民幣9670萬。抵銷這些義務,公司有人民幣25060萬的現金以及價值人民幣13370萬的應收賬款在12個月內到期。因此,公司的負債總額比其現金和近期應收賬款加起來多人民幣3820萬。

Having regard to Doctorglasses ChainLtd's size, it seems that its liquid assets are well balanced with its total liabilities. So it's very unlikely that the CN¥5.02b company is short on cash, but still worth keeping an eye on the balance sheet. While it does have liabilities worth noting, Doctorglasses ChainLtd also has more cash than debt, so we're pretty confident it can manage its debt safely.

考慮到博士眼鏡連鎖有限公司的規模,其流動資產似乎與總負債平衡。所以50.2億人民幣的公司很不可能現金短缺,但仍值得關注其資產負債表。儘管確實存在需要注意的負債,博士眼鏡連鎖有限公司的現金多於債務,因此我們相當有信心它能安全地管理債務。

But the other side of the story is that Doctorglasses ChainLtd saw its EBIT decline by 4.9% over the last year. If earnings continue to decline at that rate the company may have increasing difficulty managing its debt load. When analysing debt levels, the balance sheet is the obvious place to start. But it is future earnings, more than anything, that will determine Doctorglasses ChainLtd's ability to maintain a healthy balance sheet going forward. So if you're focused on the future you can check out this free report showing analyst profit forecasts.

但事情的另一面是,過去一年博士眼鏡連鎖有限公司的息稅前利潤(EBIt)下降了4.9%。如果收入繼續以這個速度下降,公司可能在管理債務負擔方面遇到越來越大的困難。在分析債務水平時,資產負債表是顯而易見的起點。但未來的收入,尤其是未來的收入,將決定博士眼鏡連鎖有限公司能否保持健康的資產負債表。因此,如果你專注於未來,可以查看這份免費報告顯示分析師的利潤預測。

Finally, a business needs free cash flow to pay off debt; accounting profits just don't cut it. While Doctorglasses ChainLtd has net cash on its balance sheet, it's still worth taking a look at its ability to convert earnings before interest and tax (EBIT) to free cash flow, to help us understand how quickly it is building (or eroding) that cash balance. Happily for any shareholders, Doctorglasses ChainLtd actually produced more free cash flow than EBIT over the last three years. There's nothing better than incoming cash when it comes to staying in your lenders' good graces.

最後,一家企業需要自由現金流來償還債務;會計利潤並不足夠。雖然博士眼鏡連鎖有限公司的資產負債表上有淨現金,但仍值得查看其將息稅前利潤(EBIT)轉化爲自由現金流的能力,以幫助我們了解其建立(或侵蝕)現金餘額的速度。在過去三年中,博士眼鏡連鎖有限公司實際上比EBIt產生了更多的自由現金流。對於任何股東來說,進賬現金無疑是保持與貸款人良好關係的最好方法。

Summing Up

總之

We could understand if investors are concerned about Doctorglasses ChainLtd's liabilities, but we can be reassured by the fact it has has net cash of CN¥215.6m. And it impressed us with free cash flow of CN¥224m, being 173% of its EBIT. So we don't think Doctorglasses ChainLtd's use of debt is risky. There's no doubt that we learn most about debt from the balance sheet. However, not all investment risk resides within the balance sheet - far from it. For example Doctorglasses ChainLtd has 2 warning signs (and 1 which is concerning) we think you should know about.

如果投資者關注博士眼鏡鏈有限公司的負債,我們可以理解,但是我們可以放心,它擁有21560萬人民幣的淨現金。並且,令我們印象深刻的是,其自由現金流爲22400萬人民幣,佔其EBIT的173%。因此,我們認爲博士眼鏡鏈有限公司的債務使用並不冒險。毫無疑問,我們從資產負債表中了解到大部分關於債務的信息。然而,並非所有的投資風險都存在於資產負債表中 - 遠非如此。例如,博士眼鏡鏈有限公司有2個警示信號(其中一個令人擔憂),我們認爲您應該知道。

When all is said and done, sometimes its easier to focus on companies that don't even need debt. Readers can access a list of growth stocks with zero net debt 100% free, right now.

說到底,有時候更容易集中精力關注根本不需要債務的公司。讀者可以免費訪問零淨債務增長股票列表。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論